Evidence map›Paper›PMID 19934229›Full record

ArticleRNA (New York, N.Y.)2010

Poly(A)-binding protein modulates mRNA susceptibility to cap-dependent miRNA-mediated repression.

Robert W Walters, Shelton S Bradrick, Matthias Gromeier

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. The complexity of miRNA-mediated repression.Cell death and differentiation · 2015
    Review
  14. Article
  15. Article
  16. Article
  17. A role for eIF4AII in microRNA-mediated mRNA silencing.Nature structural & molecular biology · 2013
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Robert W WaltersDepartment of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina 27710, USA.
Shelton S Bradrick
Matthias Gromeier
Duke University · US

Funding

Targeting Translation Control in Malignant GliomaR01CA124756 · NCI · DUKE UNIVERSITY · PI GROMEIER, MATTHIAS · 2007 to 2016
$2.6M
Host-pathogen interactions in hepatitis C virus replicationK01DK082613 · NIDDK · DUKE UNIVERSITY · PI BRADRICK, SHELTON STEWART · 2009 to 2013
$546k
NCI NIH HHS CA124756NCI NIH HHS R01 CA124756NIDDK NIH HHS K01 DK082613
6 · The paper itself

Abstract

MicroRNAs (miRNAs) regulate gene expression post-transcriptionally through binding specific sites within the 3' untranslated regions (UTRs) of their target mRNAs. Numerous investigations have documented repressive effects of miRNAs and identified factors required for their activity. However, the precise mechanisms by which miRNAs modulate gene expression are still obscure. Here, we have examined the effects of multiple miRNAs on diverse target transcripts containing artificial or naturally occurring 3' UTRs in human cell culture. In agreement with previous studies, we report that both the 5' m(7)G cap and 3' poly(A) tail are essential for maximum miRNA repression. These cis-acting elements also conferred miRNA susceptibility to target mRNAs translating under the control of viral- and eukaryotic mRNA-derived 5' UTR structures that enable cap-independent translation. Additionally, we evaluated a role for the poly(A)-binding protein (PABP) in miRNA function utilizing multiple approaches to modulate levels of active PABP in cells. PABP expression and activity inversely correlated with the strength of miRNA silencing, in part due to antagonism of target mRNA deadenylation. Together, these findings further define the cis- and trans-acting factors that modulate miRNA efficacy.

Indexed as

Cells, CulturedHumansMicroRNAsModels, BiologicalPoly(A)-Binding Protein IPolyadenylationRegulatory Sequences, Ribonucleic AcidRepressor ProteinsRNA-Binding ProteinsRNA Cap-Binding ProteinsRNA CapsRNA InterferenceRNA, MessengerRNA StabilityTransfectionMicroRNAsPAIP2 protein, humanPoly(A)-Binding Protein IRegulatory Sequences, Ribonucleic AcidRepressor ProteinsRNA-Binding ProteinsRNA Cap-Binding ProteinsRNA CapsRNA, Messenger

Identifiers

PMID19934229
PMCPMC2802033
OpenAlexW2123063336

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.